SecProbe.io

Filing text and metadata
Intelligence Terminal Search Topics Monthly Activity About

CORRESP Filing

WINDTREE THERAPEUTICS INC /DE/
Date: July 10, 2025 · CIK: 0000946486 · Accession: 0001437749-25-022541

Offering / Registration Process

AI Filing Summary & Sentiment

Sentiment
Urgency
Document Type
Confidence
SEC Posture
Company Posture

Summary

Reasoning

File numbers found in text: 333-287358

Date
July 10, 2025
Author
/s/ Jed Latkin
Form
CORRESP
Company
WINDTREE THERAPEUTICS INC /DE/

Letter

wint20250710_corresp.htm

Windtree Therapeutics Inc.

2600 Kelly Road, Suite 100

Warrington, Pennsylvania 18976

July 10, 2025

VIA EDGAR

Securities and Exchange Commission

Division of Corporation Finance

Office of Life Sciences

100 F Street, N.E.

Washington, D.C. 20549-3561

Re:

Windtree Therapeutics Inc.

Registration Statement on Form S-1 (the “ Registration Statement ” )

Filed July 10, 2025

File No. 333-287358

Ladies and Gentlemen:

Pursuant to Rule 461 promulgated under the Securities Act of 1933, as amended, Windtree Therapeutics Inc. (the “ Company ”) hereby requests acceleration of the effectiveness date of the above referenced Registration Statement, so that it will become effective at 9:30 a.m., Eastern Time, on July 11, 2025, or as soon thereafter as practicable, or at such other time as the Company or its outside counsel, Thompson Hine LLP, request by telephone that such Registration Statement be declared effective.

Please contact Faith L. Charles of Thompson Hine LLP, outside counsel to the Company, at (212) 908-3905, as soon as the Registration Statement has been declared effective, or if you have any other questions or concerns regarding this matter.

Sincerely,
WINDTREE THERAPEUTICS INC.

Show Raw Text
CORRESP
 1
 filename1.htm

 wint20250710_corresp.htm

 Windtree Therapeutics Inc.

 2600 Kelly Road, Suite 100

 Warrington, Pennsylvania 18976

 July 10, 2025

 VIA EDGAR

 Securities and Exchange Commission

 Division of Corporation Finance

 Office of Life Sciences

 100 F Street, N.E.

 Washington, D.C. 20549-3561

 Re:

 Windtree Therapeutics Inc.

 Registration Statement on Form S-1 (the “ Registration Statement ” )

 Filed July 10, 2025

 File No. 333-287358

 Ladies and Gentlemen:

 Pursuant to Rule 461 promulgated under the Securities Act of 1933, as amended, Windtree Therapeutics Inc. (the “ Company ”) hereby requests acceleration of the effectiveness date of the above referenced Registration Statement, so that it will become effective at 9:30 a.m., Eastern Time, on July 11, 2025, or as soon thereafter as practicable, or at such other time as the Company or its outside counsel, Thompson Hine LLP, request by telephone that such Registration Statement be declared effective.

 Please contact Faith L. Charles of Thompson Hine LLP, outside counsel to the Company, at (212) 908-3905, as soon as the Registration Statement has been declared effective, or if you have any other questions or concerns regarding this matter.

 Sincerely,

 WINDTREE THERAPEUTICS INC.

 /s/ Jed Latkin

 Jed Latkin

 Chief Executive Officer

 cc:

 Faith L. Charles (Thompson Hine LLP)